Distribution of NDM1 Carbapenemase-Producing Proteeae Strains on High-Risk Hospital Wards

References

• Adeolu M, Alnajar S, Naushad S, Gupta RS. Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morgane. Int J Syst Evol Microbiol. 2016;66(12):5575–5599. doi:10.1099/ijsem.0.00148527620848
   PubMed Web of Science ®Google Scholar
• O’Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. 2000;13(4):534–546. doi:10.1128/CMR.13.4.53411023955
   PubMed Web of Science ®Google Scholar
• Iovleva A, Doi Y. Carbapenem-Resistant Enterobacteriaceae. Clin Lab Med. 2017;37(2). doi:10.1016/j.cll.2017.01.005
   Web of Science ®Google Scholar
• Codjoe F. Carbapenem Resistance: A Review. Med Sci. 2017. doi:10.3390/medsci6010001
   Google Scholar
• Brenner FW. Who publishes list of bacteria for which new antibiotics are urgently needed. Saudi Med J. 2017.
   Google Scholar
• Cabral AB, Maciel MAV, Barros JF, Antunes MM, Lopes ACS. Detection of blaKPC-2 in Proteus mirabilis in Brazil. Rev Soc Bras Med Trop. 2015;48(1):94–95. doi:10.1590/0037-8682-0152-201425860472
   PubMed Web of Science ®Google Scholar
• Tibbetts R, Frye JG, Marschall J, Warren D, Dunne W. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC β-lactamase in P. mirabilis. J Clin Microbiol. 2008;46(9):3080–3083. doi:10.1128/JCM.00979-0818632900
   PubMed Web of Science ®Google Scholar
• Shiroto K, Ishii Y, Kimura S, et al. Metallo-β-lactamase IMP-1 in Providencia rettgeri from two different hospitals in Japan. J Med Microbiol. 2005;54(11):1065–1070. doi:10.1099/jmm.0.46194-016192438
   PubMed Web of Science ®Google Scholar
• Sheng ZK, Li JJ, Sheng GP, Sheng JF, Li LJ. Emergence of Klebsiella pneumoniae carbapenemase-producing Proteus mirabilis in Hangzhou, China. Chin Med J. 2010. doi:10.3760/cma.j.issn.0366-6999.2010.18.014
   Web of Science ®Google Scholar
• Lange F, Pfennigwerth N, Gerigk S, et al. Dissemination of bla OXA-58 in Proteus mirabilis isolates from Germany. J Antimicrob Chemother. 2017:dkw566. doi:10.1093/jac/dkw566
   Web of Science ®Google Scholar
• Potter RF, Wallace MA, McMullen AR, et al. blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri. Clin Microbiol Infect. 2018;24(9):1019.e5-1019.e8. doi:10.1016/j.cmi.2018.02.018
   Web of Science ®Google Scholar
• Lee HW, Kang HY, Shin KS, Kim J. Multidrug-resistant Providencia isolates carrying blaPER-1, blaVIM-2, and armA. J Microbiol. 2007.
   Google Scholar
• Shibata N, Doi Y, Yamane K, et al. PCR Typing of Genetic Determinants for Metallo-β-Lactamases and Integrases Carried by Gram-Negative Bacteria Isolated in Japan, with Focus on the Class 3 Integron. J Clin Microbiol. 2003;41(12):5407–5413. doi:10.1128/JCM.41.12.5407-5413.200314662918
   PubMed Web of Science ®Google Scholar
• Tsakris A, Poulou A, Themeli-Digalaki K, et al. Use of boronic acid disk tests to detect extended-spectrum β-lactamases in clinical isolates of KPC carbapenemase-possessing Enterobacteriaceae. J Clin Microbiol. 2009;47(11):3420–3426. doi:10.1128/JCM.01314-0919726597
   PubMed Web of Science ®Google Scholar
• Molnár S, Flonta MMM, Almaş A, et al. Dissemination of NDM-1 carbapenemase-producer Providencia stuartii strains in Romanian hospitals: a multicentre study. J Hosp Infect. 2019;103(2):165–169. doi:10.1016/j.jhin.2019.04.01531039380
   PubMed Web of Science ®Google Scholar
• Székely E, Damjanova I, Jánvári L, et al. First description of blaNDM-1, blaOXA-48, blaOXA-181 producing Enterobacteriaceae strains in Romania. Int J Med Microbiol. 2013;303(8):697–700. doi:10.1016/j.ijmm.2013.10.00124183483
   PubMed Web of Science ®Google Scholar
• Axente C, Licker M, Moldovan R, et al. Antimicrobial consumption, costs and resistance patterns: A two year prospective study in a Romanian intensive care unit. BMC Infect Dis 2017;17:358. doi:10.1186/s12879-017-2440-74
   Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th Ed Wayne, PA: Clinical and Laboratory Standards Institute; 2017. doi:10.1039/C4DT1694G
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012. doi:10.1111/j.1469-0691.2011.03570.x
   Web of Science ®Google Scholar
• Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.00221398074
   PubMed Web of Science ®Google Scholar
• Akhi MT, Gholizadeh P, Ghotaslu R, et al. Fecal Carriage of ESBL types TEM, SHV, CTX Producing Genera Proteus, Morganella, Providencia in Patients of Iran. Ambient Sci. 2016;3(2):80–84. doi:10.21276/ambi.2016.03.2.ra06
   Google Scholar
• Abdallah M, Balshi A. First literature review of carbapenem-resistant Providencia. New Microbes New Infect. 2018. doi:10.1016/j.nmni.2018.05.009
   Google Scholar
• Olumuyiwa Olaitan A, Diene SM, Victor Assous M, Rolain JM. Genomic plasticity of multidrug-resistant NDM-1 positive clinical isolate of providencia rettgeri. Genome Biol Evol. 2016. doi:10.1093/gbe/evv195
   Web of Science ®Google Scholar
• Barrios H, Garza-Ramos U, Reyna-Flores F, et al. Isolation of carbapenem-resistant NDM-1-positive Providencia rettgeri in Mexico. J Antimicrob Chemother. 2013;68(8):1934–1936. doi:10.1093/jac/dkt12423620464
   PubMed Web of Science ®Google Scholar
• Zurita J, Parra H, Gestal MC, McDermott J, Barba P. First case of NDM-1-producing Providencia rettgeri in Ecuador. J Glob Antimicrob Resist. 2015;3(4):302–303. doi:10.1016/j.jgar.2015.07.00327842879
   PubMed Web of Science ®Google Scholar
• Pollett S, Miller S, Hindler J, Uslan D, Carvalho M, Humphries RM. Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013. J Clin Microbiol. 2014;52(11):4003–4009. doi:10.1128/JCM.01397-1425210072
   PubMed Web of Science ®Google Scholar
• Manageiro V, Sampaio DA, Pereira P, et al. Draft genome sequence of the first NDM-1-producing Providencia stuartii strain isolated in Portugal. Genome Announc. 2015;3(5). doi:10.1128/genomeA.01077-15
   Google Scholar
• Mc Gann P, Hang J, Clifford RJ, et al. Complete sequence of a novel 178-kilobase plasmid carrying bla NDM-1 in a Providencia stuartii strain isolated in Afghanistan. Antimicrob Agents Chemother. 2012;56(4):1673–1679. doi:10.1128/AAC.05604-1122290972
   PubMed Web of Science ®Google Scholar
• Galani L, Galani I, Souli M, et al. Nosocomial dissemination of Providencia stuartii isolates producing extended spectrum β-lactamases VEB-1 and SHV-5, metallo-β-lactamase VIM-1, and RNA methylase RmtB. J Glob Antimicrob Resist. 2013;1(2):115–116. doi:10.1016/j.jgar.2013.03.00627873578
   PubMed Web of Science ®Google Scholar
• Oikonomou O, Liakopoulos A, Phee LM, Betts J, Mevius D, Wareham DW. Providencia stuartii isolates from Greece: co-carriage of cephalosporin (bla SHV-5 bla VEB-1), carbapenem (bla VIM-1), and aminoglycoside (rmtB) resistance determinants by a multidrug-resistant outbreak clone. Microb Drug Resist. 2016;22(5):379–386. doi:10.1089/mdr.2015.021527380549
   PubMed Web of Science ®Google Scholar
• Douka E, Perivolioti E, Kraniotaki E, et al. Emergence of a pandrug-resistant VIM-1-producing Providencia stuartii clonal strain causing an outbreak in a Greek intensive care unit. Int J Antimicrob Agents. 2015;45(5):533–536. doi:10.1016/j.ijantimicag.2014.12.03025749199
   PubMed Web of Science ®Google Scholar
• Robin F, Aggoune-Khinache N, Delmas J, Naim M, Novel BR. VIM metallo-β-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob Agents Chemother. 2010;54(1):466–470. doi:10.1128/AAC.00017-0919901092
   PubMed Web of Science ®Google Scholar
• Bocanegra-Ibarias P, Garza-González E, Morfín-Otero R, et al. Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico. PLoS One. 2017;12(6):e0179651. doi:10.1371/journal.pone.017965128636666
   PubMed Web of Science ®Google Scholar
• Vourli S, Tsorlini H, Katsifa H, et al. Emergence of Proteus mirabilis carrying the blaVIM-1 metallo-β-lactamase gene. Clin Microbiol Infect. 2006;12(7):691–694. doi:10.1111/j.1469-0691.2006.01489.x16774572
   PubMed Web of Science ®Google Scholar
• Bontron S, Poirel L, Kieffer N, et al. Increased Resistance to Carbapenems in Proteus mirabilis Mediated by Amplification of the blaVIM-1 -Carrying and IS 26 -Associated Class 1 Integron. Microb Drug Resist. 2019;25(5):663–667. doi:10.1089/mdr.2018.036530676261
   PubMed Web of Science ®Google Scholar
• Poirel L, Schrenzel J, Cherkaoui A, Bernabeu S, Renzi G, Nordmann P. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother. 2011;66(8):1730–1733. doi:10.1093/jac/dkr17421628303
   PubMed Web of Science ®Google Scholar
• Yang J-H, Sheng W-H, Hsueh P-R. Antimicrobial susceptibility and distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Proteus, Providencia, and Morganella isolated from global hospitalized patients with intra-abdominal and urinary tract infections. J Glob Antimicrob Resist. 2020. doi:10.1016/j.jgar.2020.04.011
   Web of Science ®Google Scholar
• Mariappan S, Sekar U, Carbapenemase-producing Enterobacteriaceae KA. Risk factors for infection and impact of resistance on outcomes. Int J Appl Basic Med Res. 2017;7(1):32. doi:10.4103/2229-516x.19852028251105
   PubMedGoogle Scholar
• Licker M, Anghel A, Moldovan R, et al. Genotype-phenotype correlation in multiresistant Escherichia coli and Klebsiella pneumoniae strains isolated in Western Romania. Eur Rev Med Pharmacol Sci. 2015;19(10):1888–1894.26044236
   PubMed Web of Science ®Google Scholar
• Abrar S, Vajeeha A, Ul-Ain N, Riaz S. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and Klebsiella pneumoniae in Lahore, Pakistan. Microb Pathog. 2017. doi:10.1016/j.micpath.2016.12.004
   Web of Science ®Google Scholar
• Wang G, Huang T, Surendraiah PKM, et al. CTX-M β-Lactamase–producing Klebsiella pneumoniae in Suburban New York City, New York, USA. Emerg Infect Dis. 2013;19(11):1803–1810. doi:10.3201/eid1911.12147024188126
   PubMed Web of Science ®Google Scholar
• Bonnin RA, Poirel L, Licker M, Nordmann P. Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals. Clin Microbiol Infect. 2011;17(10):1524–1528. doi:10.1111/j.1469-0691.2011.03622.x21883667
   PubMed Web of Science ®Google Scholar
• Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother. 2011;55(3):1274–1278. doi:10.1128/AAC.01497-1021189345
   PubMed Web of Science ®Google Scholar
• Falagas ME, Karageorgopoulos DE, Nordmann P. Therapeutic options for infections Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol. 2011;6(6):653–666. doi:10.2217/fmb.11.4921707312
   PubMed Web of Science ®Google Scholar
• Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-Type carbapenemases in Gram-negative bacteria. Biomed Res Int. 2014;2014:1–12. doi:10.1155/2014/249856
   Web of Science ®Google Scholar
• Muntean D, Licker M, Horhat F, et al. Extensively drug-resistant Acinetobacter baumannii and Proteeae association in a Romanian intensive care unit: risk factors for acquisition. Infect Drug Resist 2018;11:2187–2197. doi:10.2147/IDR.S1712886
   Google Scholar
• Baditoiu L, Axente C, Lungeanu D, et al. Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis. Ann Clin Microbiol Antimicrob 2017;16:71. doi:10.1186/s12941-017-0251-87
   Google Scholar
• Muntean D, Horhat FG, Badiţoiu L, et al. Multidrug-resistant gram-negative bacilli: a retrospective study of trends in a tertiary healthcare unit. Medicina 2018;54(6):92. doi:10.3390/MEDICINA54060092
   Google Scholar
• Licker M, Sorescu T, Rus M, et al. Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients. Infect Drug Resist 2018;11:743–749. doi:10.2147/IDR.S161069
   Google Scholar